Phase I-Ii evaluation of acronine in patients with multiple myeloma
Scarffe, J.H.; Beaumont, A.R.; Crowther, D.
Cancer Treatment Reports 67(1): 93-94
1983
ISSN/ISBN: 0361-5960 PMID: 6616497 Document Number: 207449
Document emailed within 1 workday
Related Documents
Case, D.C.; Sonneborn, H.L.; Paul, S.D.; Hiebel, J.; Boyd, M.A.; Shepp, M.A.; Dorsk, B.M.; Bonnem, E. 1986: Phase Ii study of rDNA alpha-2 interferon (INTRON A) in patients with multiple myeloma utilizing an escalating induction phase Cancer Treatment Reports 70(11): 1251-1254Cornell, C.J.; Pajak, T.F.; McIntyre, O.R. 1984: Chlorozotocin: phase Ii evaluation in patients with myeloma Cancer Treatment Reports 68(4): 685-686
Weber, D.M. 2003: Strategies in treating newly diagnosed or untreated multiple myeloma patients. from the Multiple Myeloma Research Foundation Oncology 17(6): 765-767
Kyle, R.A.; Costa, G.; Cooper, M.R.; Ogawa, M.; Silver, R.T.; Glidewell, O.; Holland, J.F. 1973: Evaluation of aniline mustard in patients with multiple myeloma Cancer Research 33(5): 956-960
Pasqualetti, P.; Casale, R.; Collacciani, A.; Colantonio, D. 1989: Evaluation of a morphologic staging method (myeloma progression score) in multiple myeloma Medicina 9(3): 280-282
Adam, Z.; Krahulová, M.; Spelda, S.; Vorlícek, J.; Hejlová, N.; Hájek, R.; Tomíska, M. 1995: Evaluation of treatment of anemia with erythropoietin in patients with multiple myeloma Vnitrni Lekarstvi 41(11): 767-772
Dingli, D.; Rajkumar, S.Vincent.; Nowakowski, G.S.; Gertz, M.A.; Dispenzieri, A.; Lacy, M.Q.; Hayman, S.; Fonseca, R.; Lust, J.A.; Kyle, R.A.; Greipp, P.R.; Witzig, T.E. 2005: Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trial Haematologica 90(12): 1650-1654
Guseva, S.A.; Tishchenko, L.M.; Minchenko, Z.N. 1985: Evaluation of changes in serum proteins by polyacrylamide gel electrophoresis in patients with multiple myeloma Vrachebnoe Delo 1: 95-99
Rosen, L.S.; Gordon, D.; Kaminski, M.; Howell, A.; Belch, A.; Mackey, J.; Apffelstaedt, J.; Hussein, M.; Coleman, R.E.; Reitsma, D.J.; Seaman, J.J.; Chen, B.L.; Ambros, Y. 2001: Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial Cancer Journal 7(5): 377-387
Bataille, R.; Morlock, G.; Rosenberg, F.; Sany, J.; Serre, H. 1978: Evaluation of the tumor mass and its regression under treatment of multiple myeloma of the bones. Critical comments apropos of 22 patients Revue du Rhumatisme et des Maladies Osteo-Articulaires 45(1): 1-5
Pastor Rubín de Celis, E.; Ruiz Salmerón, R.J.; Aguirre Jaca, M.; Rivas Manga, M.C.; Marín Hernández, G. 1992: Immunoblastic lymphoma as expression of the final phase of IgA multiple myeloma Revista Clinica Espanola 191(5): 267-269
Goranov, S.; Hristova, I.; Pencheva, K. 1994: Nephrogenic diabetes insipidus--prodromal phase of multiple myeloma Folia Medica 36(2): 63-66
Liberati, A.M.; Cinieri, S.; Senatore, M.G.; Portuesi, M.G.; De Angelis, V.; Di Clemente, F.; Schippa, M.; Ferrajoli, A.; Arzano, S.; Berruto, P. 1990: Phase I-Ii trial on natural beta interferon in chemoresistant and relapsing multiple myeloma Haematologica 75(5): 436-442
Teunissen, L.L.; Notermans, N.C. 1998: The risk of Kahler disease (multiple myeloma) in patients with a paraproteinemia: myeloma risk score, developed in the region of the Integral Cancer Center, West Nederlands Tijdschrift Voor Geneeskunde 142(43): 2374-2375
Wahner, H.W.; Kyle, R.A.; Beabout, J.W. 1980: Scintigraphic evaluation of the skeleton in multiple myeloma Mayo Clinic Proceedings 55(12): 739-746
Polishchuk, P.R.; Petrenko, L.I.; Kriuchkov, M.I.; Morozov, S.P.; Brodetskiĭ, B.M. 2010: Multiple myeloma: evaluation of invasiveness by magnetic resonance imaging Terapevticheskii Arkhiv 82(4): 64-67
Linardi, C.C.G.; Martinez, G.; Velloso, E.D.R.P.; Leal, A.M.; Kumeda, C.A.; Buccheri, V.; Azevedo, R.S.; Peliçario, L.M.; Dorlhiac-Llacer, P. 2012: Evaluation of chromosomal abnormalities by cIg-FISH and association with proliferative and apoptotic indexes in multiple myeloma Brazilian Journal of Medical and Biological Research 45(11): 1074-1079
Poley, S.; Stieber, P.; Nüssler, V.; Pahl, H.; Fateh-Moghadam, A. 1997: Evaluation of serum neural cell adhesion molecule as a prognostic marker in multiple myeloma Anticancer Research 17(4b): 3021-3024
Shimanovskaia, K.B.; Apasov, G.N.; Korytova, L.I.; Rokhlin, G.D. 1975: Clinico-radiographic analysis of the state of the spine in patients with lymphogranulomatosis and in patients with multiple myeloma Problemy Gematologii i Perelivaniia Krovi 20(10): 25-27
Barlogie, B.; Alexanian, R. 1989: Second International Workshop on Myeloma: advances in biology and therapy of multiple myeloma Cancer Research 49(24 Pt 1): 7172-7175